Longo, A.; Librizzi, M.; Chuckowree, I.S.; Baltus, C.B.; Spencer, J.; Luparello, C.
Cytotoxicity of the Urokinase-Plasminogen Activator Inhibitor Carbamimidothioic Acid (4-Boronophenyl) Methyl Ester Hydrobromide (BC-11) on Triple-Negative MDA-MB231 Breast Cancer Cells. Molecules 2015, 20, 9879-9889.
https://doi.org/10.3390/molecules20069879
AMA Style
Longo A, Librizzi M, Chuckowree IS, Baltus CB, Spencer J, Luparello C.
Cytotoxicity of the Urokinase-Plasminogen Activator Inhibitor Carbamimidothioic Acid (4-Boronophenyl) Methyl Ester Hydrobromide (BC-11) on Triple-Negative MDA-MB231 Breast Cancer Cells. Molecules. 2015; 20(6):9879-9889.
https://doi.org/10.3390/molecules20069879
Chicago/Turabian Style
Longo, Alessandra, Mariangela Librizzi, Irina S. Chuckowree, Christine B. Baltus, John Spencer, and Claudio Luparello.
2015. "Cytotoxicity of the Urokinase-Plasminogen Activator Inhibitor Carbamimidothioic Acid (4-Boronophenyl) Methyl Ester Hydrobromide (BC-11) on Triple-Negative MDA-MB231 Breast Cancer Cells" Molecules 20, no. 6: 9879-9889.
https://doi.org/10.3390/molecules20069879
APA Style
Longo, A., Librizzi, M., Chuckowree, I. S., Baltus, C. B., Spencer, J., & Luparello, C.
(2015). Cytotoxicity of the Urokinase-Plasminogen Activator Inhibitor Carbamimidothioic Acid (4-Boronophenyl) Methyl Ester Hydrobromide (BC-11) on Triple-Negative MDA-MB231 Breast Cancer Cells. Molecules, 20(6), 9879-9889.
https://doi.org/10.3390/molecules20069879